Repro Med Systems Stock Investor Sentiment

KRMD Stock  USD 3.66  0.14  3.98%   
About 72 percent of all Repro Med's shareholders are curious in acquiring. The analysis of overall sentiment of trading Repro Med Systems stock suggests that quite a large number of investors are confidant at this time. The current market sentiment, together with Repro Med's historical and current headlines, can help investors time the market. In addition, many technical investors use Repro Med Systems stock news signals to limit their universe of possible portfolio assets.
  

Repro Med Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Repro Med can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over six months ago at investing.com         
KORU Medical enters Phase III trial for rare disease therapy
Investing News at Macroaxis
over six months ago at news.google.com         
Analysts Estimate Repro Med Systems, Inc. to Report a Decline in Earnings What to Look Out for - Yah...
Google News at Macroaxis
over six months ago at news.google.com         
Silk Road Medical Reports Q4 Loss, Tops Revenue Estimates - Yahoo Canada Shine On
Google News at Macroaxis
over six months ago at www.macroaxis.com         
Acquisition by Goldberger Daniel S of 5221 shares of Repro Med at 2.87 subject to Rule 16b-3
Macroaxis News
over six months ago at finance.yahoo.com         
It Looks Like KORU Medical Systems, Inc.s CEO May Expect Their Salary To Be Put Under The Microscope
Yahoo News
over six months ago at gurufocus.com         
KORU Medical Systems Inc Q1 2024 Earnings Call Transcript Highlights Record Revenue and ...
Gurufocus Stories at Macroaxis
over six months ago at insidermonkey.com         
KORU Medical Systems, Inc. Q1 2024 Earnings Call Transcript
insidermonkey News
over six months ago at investorplace.com         
KRMD Stock Earnings KORU Medical Systems Beats EPS, Beats Revenue for Q1 2024
sbwire news
over six months ago at gurufocus.com         
KORU Medical Systems Inc Q1 2024 Earnings Revenue Surpasses Estimates Amidst Challenges
Gurufocus Stories at Macroaxis
over six months ago at seekingalpha.com         
KORU Medical Systems GAAP EPS of -0.04 in-line, revenue of 8.2M beats by 0.67M
seekingalpha News
over six months ago at zacks.com         
KORU Medical Systems Inc. Reports Q1 Loss, Tops Revenue Estimates
zacks News
over six months ago at businesswire.com         
KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024
businesswire News
over six months ago at news.google.com         
Short Interest in KORU Medical Systems, Inc. Expands By 5.6 percent - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Repro Med Systems, Inc. Delivered A Weaker ROE Than Its Industry - Yahoo Movies Canada
Google News at Macroaxis
over six months ago at seekingalpha.com         
KORU Medical Systems announces successful appeal in EU notified body review
seekingalpha News
Far too much social signal, news, headlines, and media speculation about Repro Med that are available to investors today. That information is available publicly through Repro media outlets and privately through word of mouth or via Repro internal channels. However, regardless of the origin, that massive amount of Repro data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Repro Med news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Repro Med relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Repro Med's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Repro Med alpha.

Repro Med Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Acquisition by Linda Tharby of 19681 shares of Repro Med at 2.09 subject to Rule 16b-3
09/20/2024
2
Acquisition by Manko Joseph M. Jr. of 5454 shares of Repro Med subject to Rule 16b-3
09/30/2024
3
Acquisition by Cascella Robert of 5454 shares of Repro Med at 2.75 subject to Rule 16b-3
10/01/2024
4
The past five years for KORU Medical Systems investors has not been profitable
10/03/2024
5
Albion Financial Group UT Reduces Stake in KORU Medical Systems, Inc.
10/11/2024
6
Teleflex Surpasses Q3 Earnings Estimates
10/31/2024
7
Disposition of 721781 shares by Manko Joseph M. Jr. of Repro Med subject to Rule 16b-3
11/08/2024
8
InspireMD, Inc. Reports Q3 Loss, Tops Revenue Estimates
11/12/2024
9
KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth Raises Full Year 2024 Guidance
11/13/2024
10
KORU Medical Systems Inc Q3 2024 Earnings Call Highlights Strong Revenue Growth and ...
11/14/2024
11
KORU Medical Systems to Participate in Piper Sandlers 36th Annual Healthcare Conference
11/25/2024

Complementary Tools for Repro Stock analysis

When running Repro Med's price analysis, check to measure Repro Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repro Med is operating at the current time. Most of Repro Med's value examination focuses on studying past and present price action to predict the probability of Repro Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repro Med's price. Additionally, you may evaluate how the addition of Repro Med to your portfolios can decrease your overall portfolio volatility.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm